Terman A, Brunk UT. Lipofuscin. Int J Biochem Cell Biol. 2004 Aug;36(8):1400-4.
Seehafer SS, Pearce DA. You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol Aging. 2006 Apr;27(4):576-88. Epub 2006 Feb 7.
Jung T, Höhn A, Grune T. Lipofuscin: detection and quantification by microscopic techniques. Methods Mol Biol. 2010;594:173-93.
Yanuzzi LA, Ober MD, Slakter JS, et al. Ophthalmic fundus imaging: today and beyond. Perspective. Am J Ophthalmol. 2004 Mar;137(3):511-24.
Schmitz-Valckenberg S, Fleckenstein M, Scholl HPN, Holz FG. Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol. 2009 Jan-Feb;54(1):96-117.
Janik-Papis K, Ulinska M, Krzyzanowska A, et al. Role of oxidative mechanisms in the pathogenesis of agerelated macular degeneration. Klin Oczna. 2009;111(4-6):168-73.
Holz FG, Bindewald-Wittich A, Fleckenstein M, et al; FAM-Study Group. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol. 2007 Mar;143(3):463-72.
Laemmer R, Horn FK, Viestenz A, et al. Measurement of auto-fluorescence in the parapapillary atrophic zone in patients with ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):51-8.
Szirth B, Khouri A, Bhagat N, Shahid K. New concepts in screening for vision threatening disease (1578/B43). Poster presented at Association for Research in Vision and Ophthalmology meeting, May 7, 2007; Ft. Lauderdale, Fla.
Zarbin MA, Szirth BC. Current treatment of age-related macular degeneration. Optom Vis Sci. 2007 Jul;84(7):559-72.
Roesel M, Henschel A, Heinz C, Dietzel M, Spital G, Heiligenhaus A. Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema. Graefes Arch. Clin. Exp. Ophthalmol. 247(12), 1685-1689 (2009).
